🇬🇧 BNT162b7 Monovalent (OMI BA.4/BA.5) in United Kingdom

BNT162b7 Monovalent (OMI BA.4/BA.5) (bnt162b7-monovalent-omi-ba-4-ba-5) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Status: approved

BNT162b7 Monovalent (OMI BA.4/BA.5) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United Kingdom

Frequently asked questions

Is BNT162b7 Monovalent (OMI BA.4/BA.5) approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for BNT162b7 Monovalent (OMI BA.4/BA.5) in United Kingdom?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.